On Thursday, Truist initiated coverage on BioNTech SE (NASDAQ:BNTX), a famed COVID-19 vaccine maker, in collaboration with Pfizer Inc (NYSE:PFE).
BioNTech is transitioning from a COVID-focused narrative to a story centered on oncology drug development and upcoming catalysts.
The analyst,…